Home|Journals|Articles by Year|Audio Abstracts RSS - TOC
 

Review Article



Challenges and opportunities of clinical pharmacists during COVID-19: A review of the literature

Abrar K. Thabit, Jimmy Jose.




Abstract

The success and sustainability of any profession can be evident during times of crises. Clinical pharmacists adapted and adopted multiple roles, which were an extension of their routine activities including a few new activities depending on the situation demands. Numerous studies in the literature discussed the various roles played and the activities offered by clinical pharmacists during the coronavirus disease of 2019 (COVID-19) pandemic. The challenges and opportunities faced by the clinical pharmacists during this time are worth contemplating. We aimed to summarize the challenges faced by clinical pharmacists during the pandemic and the opportunities that arose. Providing direct patient care, change in scheduling, and burnout were among the top challenges. Telehealth services and participation in guideline development and education were among the prominent opportunities. A discouraging finding was the lack of adequate recognition along with other front-line workers. The pandemic was a clear indicator of the significant role a clinical pharmacist plays in the healthcare team. Measures need to be taken by clinical pharmacists to ensure authorities are well-informed of their activities. It is also recommended to incorporate these experiences in pharmacy degree programs to ensure that pharmacists are better prepared for any future health or natural crises.

Key words: Clinical pharmacy; clinical pharmacist; COVID-19; coronavirus disease; SARS-CoV2






Full-text options


Share this Article



Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Review(er)s Central
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.